Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation

Abstract Background Myeloablative (MAC) and reduced-intensity conditioning (RIC) are established approaches for allogeneic stem cell transplantation (SCT) in acute myeloid leukemia (AML). Most deaths after MAC occur within the first 2 years after SCT, while patients surviving leukemia-free for 2 yea...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Journal of Hematology & Oncology
المؤلفون الرئيسيون:	Avichai Shimoni, Myriam Labopin, Bipin Savani, Liisa Volin, Gerhard Ehninger, Jurgen Kuball, Donald Bunjes, Nicolaas Schaap, Stephane Vigouroux, Andrea Bacigalupo, Hendrik Veelken, Jorge Sierra, Matthias Eder, Dietger Niederwieser, Mohamad Mohty, Arnon Nagler
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	BMC 2016-11-01
الموضوعات:	Acute myeloid leukemia Allogeneic stem cell transplantation Myeloablative conditioning Reduced-intensity conditioning Long-term outcome
الوصول للمادة أونلاين:	http://link.springer.com/article/10.1186/s13045-016-0347-1

مواد مشابهة

Reduced Intensity versus Full Myeloablative Conditioning in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
حسب: Kamran Alimoghaddam, وآخرون
منشور في: (2011-09-01)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
حسب: Erden Atilla, وآخرون
منشور في: (2017-02-01)

Efficacy of Total‐Body Irradiation‐based Intensified Myeloablative Regimens for Acute Leukemia—An International Collaborative Study
حسب: Yasuyuki Arai, وآخرون
منشور في: (2025-06-01)

Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT
حسب: Jiří Pavlů, وآخرون
منشور في: (2019-10-01)

Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies
حسب: Masamitsu Yanada, وآخرون
منشور في: (2022-11-01)

A Comparison of Radiation and Alkylator-Based Conditioning Therapy Regimens for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Clinician’s Perspective
حسب: Alejandro Marinos Velarde, وآخرون
منشور في: (2025-07-01)

Appropriate pre-transplant strategy for patients with myelodysplastic syndromes receiving allogeneic haematopoietic stem cell transplantation after myeloablative conditioning
حسب: Hong Wang, وآخرون
منشور في: (2023-02-01)

Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen
حسب: Maryam Behfar, وآخرون
منشور في: (2019-06-01)

Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome
حسب: Georg-Nikolaus Franke, وآخرون
منشور في: (2021-12-01)

Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?
حسب: Tahereh Rostami, وآخرون
منشور في: (2024-04-01)

Allogeneic hematopoietic stem cell transplantation with the modified myeloablative conditioning regimen for children with chronic active Epstein–Barr virus infection
حسب: Yanhui Luo, وآخرون
منشور في: (2022-12-01)

Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
حسب: Xing-yu Cao, وآخرون
منشور في: (2023-12-01)

Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia
حسب: Roberto Bono, وآخرون
منشور في: (2024-04-01)

Deep Vein Thrombosis Following Non-myeloablative Allogeneic Stem Cell Transplantation: Presentation of Three Cases and Literature Review
حسب: Evren Özdemir, وآخرون
منشور في: (2013-06-01)

Long-Term Free Survival of Two Class III β-Thalassemic Patients after Non-Myeloablative Stem Cell Transplantation
حسب: Mohammad Mahdi Adib Sereshki, وآخرون
منشور في: (2020-04-01)

The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study
حسب: Jing Ge, وآخرون
منشور في: (2018-12-01)

Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation
حسب: Longfei Gao, وآخرون
منشور في: (2021-08-01)

Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours
حسب: A. Saam Youshani, وآخرون
منشور في: (2019-02-01)

Advances in allogeneic hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children
حسب: Guangqiang Meng, وآخرون
منشور في: (2025-01-01)

Total Marrow and Lymphoid Irradiation: A New Technology Assisting in Myeloablating Before Hematopoietic Stem Cell Transplantation
حسب: SHEN Jing, وآخرون
منشور في: (2023-07-01)

Non-Myeloablative Stem Cell Transplantation in Hematologic Malig¬nancies: An Experience from the Hematology-Oncology and BMT Re¬search Center
حسب: Keyhanian S, وآخرون
منشور في: (2004-08-01)

Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
حسب: Arnon Nagler, وآخرون
منشور في: (2014-08-01)

Successfully maintained complete remission of mycosis fungoides by umbilical cord blood transplantation: a case report and literature review
حسب: Munenari Itoh, وآخرون
منشور في: (2025-04-01)

Palifermin Compared to Supersaturated Calcium Phosphate Rinse in Prevention of Severe Oral Mucositis after Stem Cell Transplantation in Patients Receiving Radiotherapy-Based Myeloablative Conditioning
حسب: Tarik Hadid, وآخرون
منشور في: (2023-02-01)

Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT
حسب: Bipin N. Savani, وآخرون
منشور في: (2016-06-01)

A reduced-toxicity myeloablative conditioning approach for hematopoietic cell transplant in juvenile myelomonocytic leukemia
حسب: Eman Elsabagh, وآخرون
منشور في: (2025-06-01)

A post-stem cell transplant risk score for Philadelphia-negative acute lymphoblastic leukemia
حسب: Dietger Niederwieser
منشور في: (2020-05-01)

Progressive substitution of posttransplant cyclophosphamide with bendamustine: A phase I study in haploidentical bone marrow transplantation
حسب: Emmanuel Katsanis, وآخرون
منشور في: (2020-07-01)

Non-Myeloablative Stem Cell Transplantation in Hematologic Malig¬nancies: An Experience from the Hematology-Oncology and BMT Re¬search Center
حسب: S Keyhanian, وآخرون
منشور في: (2004-03-01)

Exploring the aftermath of hematopoietic cell transplantation: 18-year insights into post-transplant neoplasms
حسب: Rawad Rihani, وآخرون
منشور في: (2025-07-01)

Hematopoietic stem cell transplantation in systemic sclerosis
حسب: K G Chengappa, وآخرون
منشور في: (2017-01-01)

Incidence and Risk Factors for Acute Kidney Injury after Allogeneic Stem Cell Transplantation: A Prospective Study
حسب: Andreea Andronesi, وآخرون
منشور في: (2022-01-01)

The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party
حسب: Marie T. Rubio, وآخرون
منشور في: (2016-08-01)

Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
حسب: Eolia Brissot, وآخرون
منشور في: (2017-06-01)

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
حسب: Annalisa Ruggeri, وآخرون
منشور في: (2018-03-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES.
حسب: Gabriele Magliano, وآخرون
منشور في: (2020-10-01)

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
حسب: Marie Thérèse Rubio, وآخرون
منشور في: (2015-05-01)

C3G promotes bone marrow adipocyte expansion and hematopoietic regeneration after myeloablation by enhancing megakaryocyte niche function
حسب: Óscar Herranz, وآخرون
منشور في: (2025-04-01)

Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study.
حسب: Roni Shouval, وآخرون
منشور في: (2016-01-01)

Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
حسب: Catherine J Lee, وآخرون
منشور في: (2017-11-01)